Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value
$615.08M
Total Bought
$254.78M
Total Sold
$179.14M
Net Transaction
+$75.64M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
APOGEE THERAPEUTICS INC(APGE)537,093592,093+55,00015,00639,3456.40%+24,338
VERA THERAPEUTICS INC(VERA)0470,000+470,000020,2663.29%+20,266
XENON PHARMACEUTICALS INC(XENE)460,000837,387+377,38721,18836,0505.86%+14,862
BEIGENE LTD(ONC)082,143+82,143012,8462.09%+12,846
KURA ONCOLOGY INC(KURA)191,535730,492+538,9572,75415,5812.53%+12,827
INOZYME PHARMA INC1,885,8022,642,519+756,7178,03420,2423.29%+12,208
AUTOLUS THERAPEUTICS PLC(AUTL)1,550,4083,375,000+1,824,5929,98521,5333.50%+11,548
ALNYLAM PHARMACEUTICALS INC(ALNY)00009,4491.54%+9,449
GERON CORP(GERN)02,500,000+2,500,00008,2501.34%+8,250
MADRIGAL PHARMACEUTICALS INC(MDGL)100,000115,000+15,00023,13830,7104.99%+7,572
AXSOME THERAPEUTICS INC(AXSM)50,000139,758+89,7583,98011,1531.81%+7,173
INARI MED INC20,000175,000+155,0001,2988,3971.37%+7,098
MORPHIC HLDG INC42,670225,000+182,3301,2327,9201.29%+6,688
ELEVATION ONCOLOGY INC01,268,825+1,268,82506,5091.06%+6,509
CRINETICS PHARMACEUTICALS IN(CRNX)447,095470,000+22,90515,90822,0013.58%+6,093
PERSPECTIVE THERAPEUTICS INC(CATX)05,100,000+5,100,00006,0690.99%+6,069
ABSCI CORPORATION01,025,000+1,025,00005,8220.95%+5,822
CELLDEX THERAPEUTICS INC NEW(CLDX)400,000510,000+110,00015,86421,4053.48%+5,541
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
125,000286,200+161,2001,3966,7691.10%+5,372
APELLIS PHARMACEUTICALS INC
COM
75,000165,000+90,0004,4909,6991.58%+5,209
NURIX THERAPEUTICS INC(NRIX)690,112810,253+120,1417,12211,9111.94%+4,789
SPYRE THERAPEUTICS INC(SYRE)517,554410,000-107,55411,13815,5512.53%+4,414
FULCRUM THERAPEUTICS INC(FULC)125,000550,339+425,3398445,1950.84%+4,351
MINERALYS THERAPEUTICS INC(MLYS)0327,959+327,95904,2340.69%+4,234
REZOLUTE INC(RZLT)01,600,000+1,600,00004,0800.66%+4,080
OMEROS CORP0003,6007,6321.24%+4,032
VAXCYTE INC(PCVX)25,00080,000+55,0001,5705,4650.89%+3,895
COMPASS PATHWAYS PLC(CMPS)550,0001,027,868+477,8684,8138,5521.39%+3,739
INTRA-CELLULAR THERAPIES INC050,000+50,00003,4600.56%+3,460
ARROWHEAD PHARMACEUTICALS IN(ARWR)0120,000+120,00003,4320.56%+3,432
CENTESSA PHARMACEUTICALS PLC795,729830,546+34,8176,3349,3851.53%+3,051
NEXTCURE INC01,359,037+1,359,03703,0310.49%+3,031
PROTAGONIST THERAPEUTICS INC0100,000+100,00002,8930.47%+2,893
HELIX ACQUISITION CORP II0250,000+250,00002,5880.42%+2,588
MIRUM PHARMACEUTICALS INC(MIRM)50,000160,000+110,0001,4764,0190.65%+2,543
TERNS PHARMACEUTICALS INC66,000450,000+384,0004282,9520.48%+2,524
ESTABLISHMENT LABS HLDGS INC(ESTA)228,277164,589-63,6885,9108,3781.36%+2,467
COHERUS BIOSCIENCES INC(CHRS)0003,4035,7850.94%+2,382
REGENXBIO INC(RGNX)0110,000+110,00002,3180.38%+2,318
MERSANA THERAPEUTICS INC1,000,0001,000,00002,3204,4800.73%+2,160
ARCELLX INC
COMMON STOCK
340,000300,000-40,00018,87020,8653.39%+1,995
VERONA PHARMA PLC563,824817,833+254,00911,20913,1592.14%+1,950
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
137,000202,599+65,5994292,2370.36%+1,808
WAVE LIFE SCIENCES LTD(WVE)0286,585+286,58501,7680.29%+1,768
BOSTON SCIENTIFIC CORP(BSX)025,000+25,00001,7120.28%+1,712
KRYSTAL BIOTECH INC(KRYS)25,00026,746+1,7463,1024,7590.77%+1,657
KEZAR LIFE SCIENCES INC01,761,778+1,761,77801,5880.26%+1,588
IMMATICS N.V(IMTX)200,000350,000+150,0002,1063,6790.60%+1,573
ARYA SCIENCES ACQU CORP IV0133,500+133,50001,5050.24%+1,505
CULLINAN ONCOLOGY INC(CGEM)300,000258,588-41,4123,0574,4060.72%+1,349
SPRINGWORKS THERAPEUTICS INC100,000100,00003,6504,9220.80%+1,272
ZURA BIO LTD(ZURA)0450,009+450,00901,1570.19%+1,157
TRAVERE THERAPEUTICS INC(TVTX)0125,000+125,00009640.16%+964
ASTRIA THERAPEUTICS INC1,466,465845,606-620,85911,26211,9021.94%+639
Q32 BIO INC(FIXX)027,777+27,77704730.08%+473
PASSAGE BIO INC(PASG)0264,266+264,26603570.06%+357
SAVARA INC(SVRA)1,150,0001,150,00005,4055,7270.93%+322
AVALO THERAPEUTICS INC(AVTX)010,000+10,00002180.04%+218
AVROBIO INC500,000700,000+200,0006808960.15%+216
PROMIS NEUROSCIENCES INC265,958265,95803065080.08%+202
CASSAVA SCIENCES INC024,200+24,2000980.02%+98
CONTEXT THERAPEUTICS INC(CNTX)328,817328,81703724540.07%+82
ROCKET PHARMACEUTICALS INC(RCKT)75,00075,000037220.00%-14
ARAVIVE INC346,5110-346,511430—-43
IMMATICS N.V187,204187,20405474870.08%-60
TEVA PHARMACEUTICAL INDS LTD(TEVA)1,900,0001,400,000-500,00019,83619,7543.21%-82
INFLARX NV(IFRX)200,0970-200,0973260—-326
ROIVANT SCIENCES LTD(ROIV)500,000500,00005,6155,2700.86%-345
NUVATION BIO INC(NUVB)250,0000-250,0003780—-377
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)70,98875,000+4,0124,2873,7670.61%-520
TOURMALINE BIO INC68,08150,000-18,0811,7821,1450.19%-637
PUMA BIOTECHNOLOGY INC(PBYI)202,3490-202,3498760—-876
BIOHAVEN LTD(BHVN)20,8660-20,8668930—-893
VIRIDIAN THERAPEUTICS INC(VRDN)50,0000-50,0001,0890—-1,089
ALLOGENE THERAPEUTICS INC400,0000-400,0001,2840—-1,284
NEUROCRINE BIOSCIENCES INC(NBIX)10,0000-10,0001,3180—-1,318
VIKING THERAPEUTICS INC(VKTX)300,00050,000-250,0005,5834,1000.67%-1,483
KALVISTA PHARMACEUTICALS INC125,9690-125,9691,5430—-1,543
NUVALENT INC175,000150,000-25,00012,87811,2641.83%-1,615
ADC THERAPEUTICS SA(ADCT)1,013,5400-1,013,5401,6820—-1,682
BRIDGEBIO PHARMA INC(BBIO)80,00050,000-30,0003,2301,5460.25%-1,684
TANGO THERAPEUTICS INC(TNGX)300,274150,274-150,0002,9731,1930.19%-1,780
PENUMBRA INC(PEN)7,5000-7,5001,8870—-1,887
BRIDGEBIO PHARMA INC(BBIO)00020,57918,2982.97%-2,280
ASCENDIS PHARMA A/S(ASND)20,0000-20,0002,5190—-2,519
EYEPOINT PHARMACEUTICALS INC(EYPT)109,9000-109,9002,5400—-2,540
ARGENX SE(ARGX)7,5000-7,5002,8530—-2,853
RELAY THERAPEUTICS INC(RLAY)300,0000-300,0003,3030—-3,303
ASTRAZENECA PLC(AZN)60,0000-60,0004,0410—-4,041
DYNAVAX TECHNOLOGIES CORP300,0000-300,0004,1940—-4,194
IMMUNOVANT INC(IMVT)345,000285,000-60,00014,5359,2081.50%-5,326
MIRATI THERAPEUTICS INC100,0490-100,0495,8780—-5,878
CYTOKINETICS INC(CYTK)160,00080,000-80,00013,3585,6090.91%-7,750
ALKERMES PLC(ALKS)356,38475,000-281,3849,8862,0300.33%-7,856
LIANBIO(LIANY)3,779,6940-3,779,69416,8950—-16,895
CEREVEL THERAPEUTICS HLDNG I750,000300,000-450,00031,80012,6812.06%-19,119
CYMABAY THERAPEUTICS INC1,090,4410-1,090,44125,7560—-25,756
IMMUNOGEN INC1,404,6080-1,404,60841,6470—-41,647
Page 1 of 1
Affinity Asset Advisors, LLC — 13F Holdings — Q1 2024 | TickerTrail